Remicade (infliximab)

infliximab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Remicade (infliximab), covering 2011-05-19 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease [Phase 4]